Zenas BioPharma (ZBIO) Revenue & Revenue Breakdown
Zenas BioPharma Revenue Highlights
Latest Revenue (Y)
$10.00M
Zenas BioPharma Revenue by Period
Zenas BioPharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $10.00M | 100.00% |
| 2024-12-31 | $5.00M | -90.00% |
| 2023-12-31 | $50.00M | 100.00% |
| 2022-12-31 | - | - |
Zenas BioPharma generated $10.00M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Zenas BioPharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $10.00M | 100.00% |
| 2024-12-31 | $5.00M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2023-09-30 | $50.00M | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | - |
Zenas BioPharma generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Zenas BioPharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NVAX | Novavax | $1.12B | $70.44M |
| SNDX | Syndax Pharmaceuticals | $172.35M | $45.87M |
| WVE | Wave Life Sciences | $42.73M | $7.61M |
| RLAY | Relay Therapeutics | $15.36M | - |
| ZBIO | Zenas BioPharma | $10.00M | - |
| UPB | Upstream Bio | $2.85M | $683.00K |
| INBX | Inhibrx Biosciences | $1.30M | - |
| NTLA | Intellia Therapeutics | - | $13.78M |
| TRVI | Trevi Therapeutics | - | - |
| AMLX | Amylyx Pharmaceuticals | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |